Careers

Diversity

With 18 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

A Refocused China Initiative: DOJ’s New White Collar Enforcement Strategy

The CHOICE Act: A New Era for Noncompete Agreements in Florida

AD Nauseam

AD Nauseam: Phyllis!

Camille Bent Takes Part in Panel on Subsequent-Transfer Claims at Central States Bankruptcy Workshop

Jeff has also negotiated numerous license agreements on behalf of clients and routinely provides strategic patent prosecution guidance and patent diligence advice in connection with high value transactions. In view of his breadth of experience, he is a partner in both of our Patent Prosecution Groups - IP Life Sciences and Advanced Materials as well as IP Technology.

Jeff&nbsp;works at the cutting edge of science and technology to develop and protect clients’ intellectual property. He helps clients, including many startups and early-stage companies, draft IP-critical agreements such as licenses, joint-development agreements and joint-venture agreements. He also works with clients to develop IP strategies, patent portfolios and licensing strategies, utilizing his extensive technical background. Similarly, Jeff advises venture capital and private equity firms by providing critical evaluations of the IP portfolios of their target investments.

A frequent lecturer on IP and a frequently cited author, Jeff is well versed in the trends and nuances of multiple industries, including biotechnology, pharmaceuticals, medical devices, nanotechnology, advanced materials, 3-D printing, electronics, augmented reality / virtual reality (AR/VR), artificial intelligence and computer science. Through his many outreach activities with students, scientists, engineers and business professionals at the local and national levels, Jeff maintains a strong network throughout the innovation infrastructure of the U.S.

core/freeform

J.D., Temple University Beasley School of Law, 2001

Certificate in Business Management, University of Pennsylvania, 

Ph.D., Chemical Engineering, University of Minnesota, 1993

M.E., Chemical Engineering, Stevens Institute of Technology, 1988

B.S.E., Chemical Engineering, Princeton University, 1986, 

<ul>
<li>Pennsylvania Super Lawyers
<ul>
<li>&#8220;Rising Star&#8221; (2008, 2011)</li>
<li>&#8220;Top Young Patent Lawyer in Pennsylvania&#8221; (2008)</li>
</ul>
</li>
<li><em>Managing Intellectual Property</em> &#8220;IP Star&#8221; in Pennsylvania (2013)</li>
<li>Ben Franklin Technology Partners of Southeastern Pennsylvania: Recognition for Distinction of Service to the Nanotechnology Commercialization Review Committee (2008)</li>
<li>Wharton Business Plan Competition
<ul>
<li>Mentored Grand Prize Winners (2006, 2008)</li>
<li>Mentored Second Place &#8220;People’s Choice Award&#8221; Winner (2008)</li>
</ul>
</li>
</ul>


Philadelphia

Philadelphia Office Hosts 7th Philly Hardware Meetup: MedTech Edition for Medical Device Development Community

Remarkable Achievements: IP Teams Earn Three Practice and 16 Individual Rankings

Intellectual Property

IP Technology

Noncompete and Trade Secrets

IP Life Sciences and Advanced Materials

Emerging Companies and Venture Capital

Software

Web3 and Digital Assets

Industries

Life Sciences

Design Patent Protection

Patent Prosecution

Enterprise Issues

Implementing an IP Strategy

<ul>
<li>Negotiated and drafted numerous in-bound license agreements for early stage life science clients that are developing a wide variety of technologies pertaining to biologics, nucleic acids, small molecules, antibodies, genetics, vaccines, immunotherapies, protein therapies, blood purification, medical devices, diagnostics, gene therapies and bioinformatics.</li>
<li>Counseled an emerging biotechnology company in the area of orphan drug biologics on all IP matters. Established the IP strategy, developed the IP portfolio, handled all IP-related agreements (NDA, JRA, licensing) with joint development partners, developed freedom-to-operate (FTO) strategies and opinions, and represented the company during multiple licensing and acquisition opportunities, culminating in the sale of the company in excess of $100 million.</li>
<li>Was hired by a prominent Silicon Valley venture capital firm to handle the IP development and patenting strategies for an early-stage company that was developing a variety of nanocomposite materials. Developed licensing strategies for the resulting IP portfolio arising from a university research program. Worked with the university technology transfer office to establish an invention disclosure review and patent drafting process.</li>
<li>Worked extensively with university researchers to develop a pioneering patent in the field of bionanotechnology for genomic-length DNA management and analysis that was cited in MIT Technology Review as &#8220;one of the top ten technologies to impact your life.&#8221; Developed the IP strategy and patent portfolio for the early-stage company/licensee of this bionanotechnology. Represented the company and handled the IP due-diligence activities of the company through three rounds of financing (Angel, Series A, Series B).</li>
<li>Served as the IP strategist and patent portfolio developer for a number of emerging clean technology companies developing a variety of electronic components and control systems for generating, monitoring, managing and controlling renewable electric power in wind, solar, fuel cell, battery storage and electric vehicle applications.</li>
<li>Served as the IP strategist for a company developing bleeding edge high-speed electro-optic modulators for use in fiber-optic networks. Analyzed an extensive patent portfolio and established that the company owned a number of pioneering patents covering its market. Developed licensing strategies. Counseled senior management and the board of directors during the sale of the company to a leading multinational internet equipment company. Increased the company’s valuation by nearly $70 million through a formalized IP analysis and licensing strategy.</li>
<li>Served as IP counsel to a company developing lightweight composite components for use in the transportation industry.</li>
<li>Advised several state-based venture capital funds regarding the IP portfolios of various emerging stage companies in nanomaterials and medical devices.</li>
<li>Represented a Silicon Valley venture capital firm during its investment in a &#8220;green&#8221; wastewater treatment company. Analyzed the target company&#8217;s IP portfolio and related IP ownership issues.</li>
<li>Served as IP counsel for an emerging-stage women&#8217;s healthcare company. Developed an IP strategy and patent portfolio with the company&#8217;s founder, a prominent obstetrician/gynecologist. Counseled the company through several licensing and joint development opportunities.</li>
<li>Served as the temporary in-house patent counsel for the ophthalmic device division of a multinational healthcare company.</li>
</ul>
